Group CEO of CordLife Ltd
Dr. Steven Fang has over two decades of experience in growing life sciences businesses. Dr Fang was the Group CEO of CordLife Ltd, a cord blood banking group based in Singapore. CordLife was founded in May 2001 by Dr Fang, and has since grown to have five cord blood processing and storage facilities, in Singapore, Hong Kong, Jakarta, Indonesia, Kolkata, India, and in Sydney, Australia. The company was listed on the Australian Stock Exchange in 2004, and spun off a separate entity in 2010, which subsequently was listed on the Singapore Stock Exchange. Prior to CordLife, Dr Fang held various management positions in life sciences companies such as Becton Dickinson, Baxter Healthcare and Sterling Pharmaceuticals (now part of GSK).
Senior Fellow, A*STAR
Consultant to ETPL, A*STAR
Adjunct Prof, Duke-NUS CTeD
Prof Steven Myint is a physician with global experience in health and biomedical management. He is actively involved in the commercialization of biomedical and bio-engineering research throughout the world and is serving on the boards of companies from Singapore, Finland, USA and India. Since starting his first spinout in 2005, Prof Myint has been involved in the development of over 30 SME’s in life sciences and created over $1 billion value for shareholders.
Principle Investigator, Mechanobiology Institute
Group Leader, A*STAR
Founding Scientist, HistoIndex Pte Ltd
Dr. Hanry Yu was trained as a cell biologist under the tutorage of Prof. Michael Sheetz at Duke University, USA, and with Gareth Griffiths at EMBL, Germany. In Singapore since 1997, he ventured into Biomaterials, Tissue Engineering, Biophotonics, Computation and Systems Biology, and Mechanobiology; published over 150 high quality papers in these interface areas; filed >40 inventions that result in 3 startups; and delivered >220 invited talks. He consults for international agencies and institutions and takes pride in mentoring over 100 graduate students and staffs who moved onto successful career in academia and industry. He has been a professor of physiology and mechanobiology at the National University of Singapore; group leader at the Institute of Bioengineering and Nanotechnology, A*STAR, visiting professor at MIT, USA since 2008, and a handling editor of Biomaterials.
Founder & Managing Partner, Coffee Ventures
Dr. Eddy Lee has invested in and supported more than 50 startups predominantly in the US, Singapore and Indonesia. Interest areas include mobile health, big data, IoT and marketplaces. He has recently relocated from the Silicon Valley to Southeast Asia to tackle unmet needs in emerging markets. He works with entrepreneurs in product development, enterprise partnership, M&A exit, and entering international markets such as the US, Japan, Singapore and Indonesia. At Stanford University, Eddy concurrently serves as a Consulting Professor at the School of Medicine, where he connects academic projects with commercial opportunities. He is also a mentor at Stanford's StartX incubator where he helps startups in cross border opportunities. During his career at Stanford, Singapore and Australia, he has devised medical imaging technology for visualizing stem cell migration and therapy. He used to design semiconductor chips at Marvell, a NASDAQ-listed Southeast Asia success story which he hopes his portfolio startups could one day emulate.
Director, Educational Development Unit, Singapore National Eye Center
Dr. Jayabaskar is a dedicated medical professional with clinical, management and policy development expertise, with over ten years of professional experience in government agencies, academic, industry and local health care institutions and non-profit sector, etc. He has more than ten years of extensive accomplishments within diverse clinical environments utilizing excellent management, analytical, organizational, and people skills. He also has more than eight years of senior-level management experience in the administration of academic and research organizations. Dr. Jayabaskar is currently working as Director of Educational Development Unit, Training & Education Department, SNEC. He was Deputy Director, Academic Affairs, Ophthalmology and Visual Sciences Academic Clinical Program at SNEC and Worked as Assistant Director for strategic programs and grant management at the National Medical Research Council (NMRC), Ministry of Health, Singapore. He has worked with prominent clinician scientists, boards of directors, and executive leadership.
Ee Bin LIEW
Ee Bin Liew is the Owner of Access-2-Healthcare, a regional product commercialization and market access consulting company focusing on connecting business partners to commercialize healthcare innovations to various markets - specifically in areas of healthcare business due diligence, commercialization solutions from concept to market, and market access activities such as regulatory, quality & trade compliance. Ee Bin has extensive experience in the medical device industry with large multi-national companies, where he was in various regional executive management and leadership roles of multi-cultural teams and organizations in Asia Pacific. Ee Bin is very active in global regulatory harmonization efforts for many years, and he is currently in his second term as the co-chair for the Asian Harmonization Working Party’s (AHWP) Technical Committee Workgroup for Quality Management Systems – Operation and Implementation. Ee Bin is also contributing towards to the development of the ISO13485 Standard as a member of ISO/TC210, Workgroup 1 - Application of quality systems to medical devices.
Joanne TAN San Mui
Manager, Research Strategy and Support, SingHealth
Joanne TAN has vast experiences both in the Financial and R&D sectors. Special interest in facilitate projects / companies ambitious growth plans. Proven ability to constantly challenge and improve existing processes and systems. Versatile background, having worked in Ernst & Young, Agilent MNC, and two largest academia in Singapore, NUHS and Singhealth. Handled a big portfolio of grants, product development, med tech, and nurtured research and development among engineers and doctors , fostering collaboration both international and local companies and institutions. Having profound experience with setting up division, research team, clinical trial team and research journal and research society. Successful lead, development and motivation of employees to deliver high performance. Personally a keen investor, actively engaging in business development, reading up world financial and economic situations, sourcing opportunities for both the start-ups and institutions.